Journal
CANCER CELL
Volume 25, Issue 5, Pages 682-696Publisher
CELL PRESS
DOI: 10.1016/j.ccr.2014.03.009
Keywords
-
Categories
Funding
- National Key Basic Research Program of China [2010CB911903, 2013CB530503]
- National Natural Science Foundation of China [30572122, 81222039, 81172851, 30771984, 81123006]
- National Excellent Doctoral Dissertation of China [200775]
- National 863 Project [SS2014AA020801]
- Shanghai Committee of Science and Technology [10DZ1910300, 11QH1402900]
Ask authors/readers for more resources
Ras-related small GTPases play important roles in cancer. However, the roles of RBJ, a representative of the sixth subfamily of Ras-related small GTPases, in tumorigenesis and tumor progression remain unknown. Here, we report that RBJ is dysregulated in human gastrointestinal cancers and can promote carcinogenesis and tumor progression via nuclear entrapment of mitogen-activated protein/extracellular signal-regulated kinase (ERK) kinase (MEK) 1/MEK2 and activation of ERK1/ERK2. Nucleus-localized RBJ interacts with MEK/ERK and prolongs the duration of MEK/ERK activation. Rbj deficiency abrogates nuclear accumulation of MEK1/MEK2, attenuates ERK1/ERK2 activation, and impairs AOM/DSS-induced colonic carcinogenesis. Moreover, Rbj knockdown inhibits growth of established tumors. Our data suggest that RBJ may be an oncogenic Ras-related small GTPase mediating nuclear accumulation of active MEK1/MEK2 in tumor progression.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available